Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Chipotle

Franco-Nevada C

HEICO

Leidos Hld

Microsoft

NextEra Energy

Recent market volatility on the back of coronavirus fears makes this a good time stock up on quality stocks with long-term stability.

7 Large-Cap Stocks to Buy For Insulation From Volatility

Koninklijke Philips' (PHG) fourth-quarter results reflect robust performance in the Diagnosis & Treatment business despite negative impact from tariffs.

Koninklijke Philips' (PHG) Q4 Earnings & Sales Rise Y/Y

Philips to repurchase up to 6 million shares to cover long-term incentive and employee stock purchase plans

Koninklijke Philips N.V. (PHG) CEO Frans van Houten on Q4 2019 Results - Earnings Call Transcript

Four-year data from ILLUMENATE Pivotal trial reaffirms safety profile of Philips Stellarex low-dose Drug-Coated Balloon

Philips to review options for its Domestic Appliances business

Boston Scientific

ResMed

Growth in the COPD devices market can be attributed to factors like steadily rising geriatric population, increasing incidence of smoking and chronic respiratory diseases.

COPD Devices Gain Regulatory Go-Ahead: 3 Stocks in Focus

Philips (PHG) partners with UNFPA and the Congo government to reduce maternal and newborn mortality rate in the country.

Philips Inks Partnerships to Reduce Mortality Rates in Congo

Philips marks new milestones to improve people’s health across the globe at WEF 2020

Philips partners with the United Nations Population Fund and the Government of Republic of the Congo to reduce maternal and newborn mortality

GERMANTOWN, Md., Jan.  13, 2020  (GLOBE NEWSWIRE) --   Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a leading cell and gene therapy enabling company providing centralized CDMO manufacturing and development services through its subsidiary MTH Global, Inc., as well as localized point-of-care development and processing centers, today announced that Mario Philips was appointed to Orgenesis’ Board of Directors.

Orgenesis Appoints Industry Veteran Mario Philips to its Board of Directors

The Dutch electronics giant battled Chinese-American trade tariffs to deliver solid growth in key markets -- including both America and China.

Why Royal Philips Shares Rose 39% Last Year

Viewster App Now Available Worldwide on Selected ZEASN-Supported Philips TVs, Furthering Cinedigm’s Reach Into the Major Smart TV Manufacturer Viewster App Now Available Worldwide on Selected ZEASN-Supported Philips TVs, Furthering Cinedigm’s Reach Into the Major Smart TV Manufacturer

Cinedigm Establishes International Distribution Footprint, Re-Launching the Popular Viewster App Worldwide on Philips Televisions via ZEASN

Philips (PHG) announces new consumer focused digital health solutions to strengthen healthcare portfolio.

Philips' New Digital Health Solutions Expand Portfolio

January 6, 2020                                                                                          

Philips expands its range of consumer-focused digital health solutions at CES 2020

Philips completes cancellation of 8.54 million shares

Philips to nominate Feike Sijbesma and Peter Löscher as members of the Supervisory Board

Philips (PHG) inks partnership with Regional Medical Centre to drive innovation and expand its market share in the healthcare sector.

Philips Partners With RMC to Innovate Imaging Solutions

Philips and Regional Medical Center announce USD 16 million, long-term strategic partnership to innovate patient care for residents of rural South Carolina

Philips (PHG) expands footprint in the health tech space with the introduction of next- generation imaging solution.

Philips' New Imaging Solution Expands Healthcare Portfolio

Philips and Paige team up to bring Artificial Intelligence (AI) to clinical pathology diagnostics

Philips demonstrates innovation leadership in MR at RSNA

Philips and Inspira Health announce USD 50 million, long-term strategic partnership to transform patient care for residents of southern New Jersey, U.S.

Philips highlights AI-powered solutions focus to realize precision diagnosis at RSNA 2019

Philips extends AI portfolio with launch of IntelliSpace AI Workflow Suite to seamlessly integrate applications across imaging workflows

News for Royal Philips Stock (PHG)